Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN

Blood (2020) 136 (18): 2051–2064.

https://doi.org/10.1182/blood.2019004095

Published: 2020

Includes: Supplemental data

Journal Articles

The Kinetic Of Bone Marrow Fibrosis Regression Predicts Outcome In Myelofibrosis Patients After Allogeneic SCT

Nicolaus Kröger, MD, Haefaa Alchalby, MD, Tatjana Zabelina, MD, Hans-Michael Kvasnicka, MD, Juergen Thiele, MD, PhD, Guntram Büsche, MD, Hans Kreipe, MD

Blood (2013) 122 (21): 2078.

https://doi.org/10.1182/blood.V122.21.2078.2078

Published: 2013

Journal Articles

Telomere Length Of Granulocytes Significantly Increases During The First Six Months Of Lenalidomide Treatment In Patients With Isolated 5q- Syndrome

Fabian Beier, MD, Ulrich Germing, MD, Guntram Büsche, MD, Patrick Ziegler, PhD, Stefan Wilop, MD, Lucia Vankann, Norbert Gattermann, MD, Uwe Platzbecker, MD, PhD, Aristoteles Giagounidis, MD, PhD, Katharina S. Götze, MD, Wolf-Karsten Hofmann, Detlef Haase, MD, PhD, Hans Kreipe, MD, Jens Panse, MD, Tim H. Brümmendorf, MD

Blood (2013) 122 (21): 2781.

https://doi.org/10.1182/blood.V122.21.2781.2781

Published: 2013

Journal Articles

Pomalidomide In MPN–associated Myelofibrosis With Cytopenia: Results Of The Mpnsg 01-09 Study

Blood (2013) 122 (21): 2822.

https://doi.org/10.1182/blood.V122.21.2822.2822

Published: 2013

Journal Articles

SRSF2 mutation is present in the hypercellular and prefibrotic stage of primary myelofibrosis

Ulrich Lehmann, Stephan Bartels, Britta Hasemeier, Robert Geffers, Jerome Schlue, Guntram Büsche, Kais Hussein, Hans Kreipe

Blood (2013) 121 (19): 4011–4012.

https://doi.org/10.1182/blood-2012-11-467662

Published: 2013

Journal Articles

IDH mutation analysis is not suitable for the routine molecular diagnostic algorithm in myeloproliferative and myelodysplastic neoplasms

Kais Hussein, Bianca M. Engelhardt, Hans Kreipe, Oliver Bock

Blood (2010) 116 (23): 5073–5074.

https://doi.org/10.1182/blood-2010-06-290791

Published: 2010

Journal Articles

Short Telomeres Before Lenalidomide Treatment Predict Leukemic Progression In Patients with Myelodysplastic Syndrome and Deletion 5q

Gudrun Göhring, Kathrin Lange, Winfried Hofmann, Kirsten Vang Nielsen, Eva Hellström-Lindberg, Lydia Roy, MD, Michael Morgan, Hans Kreipe, Guntram Büsche, Aristoteles Giagounidis, Brigitte Schlegelberger

Blood (2010) 116 (21): 30.

https://doi.org/10.1182/blood.V116.21.30.30

Published: 2010

Journal Articles

New G-CSF-Dependent Signaling Pathway and Its Role In Patients with Severe Congenital Neutropenia and Acute Myeloid Leukemia

Julia Skokowa, Dr, Elena Chirvon, Lan Dan, Kshama Gupta, Ana Gigina, Marlene Reuter, Annette Müller Brechlin, Kais Hussein, Esteban Carrizosa, Janis Burkhardt, Hans Kreipe, Karl Welte, MD

Blood (2010) 116 (21): 385.

https://doi.org/10.1182/blood.V116.21.385.385

Published: 2010

Journal Articles

Patients with Del(5q) MDS Who Fail to Achieve Erythroid or Cytogenetic Remission After Treatment with Lenalidomide Have An Increased Risk for Clonal Evolution and AML Progression.

Gudrun Göhring, MD, Aristoteles Giagounidis, Guntram Büsche, MD, Hans Kreipe, MD, Martin Zimmermann, PhD, Eva Hellstrom-Lindberg, MD, PhD, Carlo Aul, Brigitte Schlegelberger, M.D.

Blood (2009) 114 (22): 3818.

https://doi.org/10.1182/blood.V114.22.3818.3818

Published: 2009

Journal Articles

Anti-Angiogenic in-Vivo Effect of Lenalidomide and Its Impact On Neoplastic and Non-Neoplastic Hematopoiesis in MDS with Del(5q) Chromosome Abnormality.

Guntram Buesche, MD, Stephanie Dieck, Aristoteles Giagounidis, MD, Gudrun Göhring, MD, Brigitte Schlegelberger, MD, Robert Knight, MD, Carlo Aul, MD, Hans Kreipe, MD

Blood (2009) 114 (22): 3800.

https://doi.org/10.1182/blood.V114.22.3800.3800

Published: 2009

Journal Articles

RBC Transfusion Independence and Safety Profile of Lenalidomide 5 or 10 mg in Pts with Low- or Int-1-Risk MDS with Del5q: Results From a Randomized Phase III Trial (MDS-004).

Pierre Fenaux, Aristotle Giagounidis, Dominik Selleslag, MD, Odile Beyne-Rauzy, MD, PhD, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath, Moshe Mittelman, MD, Petra Muus, MD, PhD, Peter te Boekhorst, MD, PhD, Guillermo Sanz, MD, PhD, Consuelo del Cañizo, Agnes Guerci-Bresler, Brigitte Schlegelberger, M.D., Carlo Aul, Hans Kreipe, MD, Gudrun Goehring, Robert Knight, MD, John Francis, Tommy Fu, Eva Hellstrom-Lindberg, MD, PhD

Blood (2009) 114 (22): 944.

https://doi.org/10.1182/blood.V114.22.944.944

Published: 2009

Journal Articles

Severe Early-Onset Inflammatory Bowel Disease Caused by IL10 Receptor Deficiency Can Be Cured by Allogeneic Hematopoietic Stem Cell Transplantation.

Blood (2009) 114 (22): 713.

https://doi.org/10.1182/blood.V114.22.713.713

Published: 2009

Journal Articles

Biclonal expansion and heterogeneous lineage involvement in a case of chronic myeloproliferative disease with concurrent MPL W515L /JAK2 V617F mutation

Kais Hussein, Oliver Bock, Katharina Theophile, Jerome Schlue, Matthias Ballmaier, Nicolaus Kröger, Gudrun Göhring, Guntram Büsche, Hans Kreipe

Blood (2009) 113 (6): 1391–1392.

https://doi.org/10.1182/blood-2008-01-136499

Published: 2009

Includes: Supplemental data

Journal Articles

Ectopic Expression of the Extracellular Domain of Mpl Is Sufficient to Induce a Hematopoietic Population Crisis

Daniel C. Wicke, Johann Meyer, Guntram Büsche, MD, Hans Kreipe, MD, Zhixiong Li, MD, Karl Welte, Matthias Ballmaier, Christopher Baum, Ute Modlich

Blood (2008) 112 (11): 2886.

https://doi.org/10.1182/blood.V112.11.2886.2886

Published: 2008

Journal Articles

Long-Term Cytogenetic Follow-up of MDS Patients with 5q- Treated within the MDS-003 (CC-5013-MDS-003) Study: Evolution to Complex Clones and Progression to AML.

Gudrun Göhring, MD, Aristoteles Giagounidis, Carlo Aul, Guntram Büsche, MD, Hans Kreipe, MD, Eva Hellström-Lindberg, MD, PhD, Robert D. Knight, MD, Brigitte Schlegelberger, MD

Blood (2008) 112 (11): 1647.

https://doi.org/10.1182/blood.V112.11.1647.1647

Published: 2008

Journal Articles

In CML, Marrow Fibrosis Relapses or Emerges in 5 - 6 % of Patients Per Year Independently Indicating Imatinib Failure and Shortened Survival Time of Patients.

Guntram Buesche, Rudiger Hehlmann, Arnold Ganser, Hartmut Hecker, Andreas Hochhaus, Hermann Heimpel, Barbara Heinze, Claudia Schoch, PD., Dorothea Gadzicki, Martin Mueller, Nils von Neuhoff, Susanne Schnittger, PD., Brigitte Schlegelberger, Bernd Frye, Axel Georgii, Hans Kreipe

Blood (2006) 108 (11): 2195.

https://doi.org/10.1182/blood.V108.11.2195.2195

Published: 2006

Journal Articles

Low level of DAP-kinase DNA methylation in myelodysplastic syndrome

Kai Brakensiek, Florian Länger, Hans Kreipe, Ulrich Lehmann

Blood (2004) 104 (5): 1586–1588.

https://doi.org/10.1182/blood-2004-03-0898

Published: 2004

Journal Articles

Megakaryocytes from chronic myeloproliferative disorders show enhanced nuclear bFGF expression

Oliver Bock, Jerome Schlué, Ulrich Lehmann, Reinhard von Wasielewski, Florian Länger, Hans Kreipe

Blood (2002) 100 (6): 2274–2275.

https://doi.org/10.1182/blood-2002-06-1811

Published: 2002

Journal Articles

Cyclin D1 Expression in Mantle Cell Lymphoma Is Accompanied by Downregulation of Cyclin D3 and Is Not Related to the Proliferative Activity

M. Michaela Ott, Jirina Bartkova, Jiri Bartek, Alexander Dürr, Lars Fischer, German Ott, Hans Konrad Müller-Hermelink, Hans Kreipe

Blood (1997) 90 (8): 3154–3159.

https://doi.org/10.1182/blood.V90.8.3154

Published: 1997

NARROW

Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN

The Kinetic Of Bone Marrow Fibrosis Regression Predicts Outcome In Myelofibrosis Patients After Allogeneic SCT

Telomere Length Of Granulocytes Significantly Increases During The First Six Months Of Lenalidomide Treatment In Patients With Isolated 5q- Syndrome

Pomalidomide In MPN–associated Myelofibrosis With Cytopenia: Results Of The Mpnsg 01-09 Study

SRSF2 mutation is present in the hypercellular and prefibrotic stage of primary myelofibrosis

IDH mutation analysis is not suitable for the routine molecular diagnostic algorithm in myeloproliferative and myelodysplastic neoplasms

Short Telomeres Before Lenalidomide Treatment Predict Leukemic Progression In Patients with Myelodysplastic Syndrome and Deletion 5q

New G-CSF-Dependent Signaling Pathway and Its Role In Patients with Severe Congenital Neutropenia and Acute Myeloid Leukemia

Patients with Del(5q) MDS Who Fail to Achieve Erythroid or Cytogenetic Remission After Treatment with Lenalidomide Have An Increased Risk for Clonal Evolution and AML Progression.

Anti-Angiogenic in-Vivo Effect of Lenalidomide and Its Impact On Neoplastic and Non-Neoplastic Hematopoiesis in MDS with Del(5q) Chromosome Abnormality.

RBC Transfusion Independence and Safety Profile of Lenalidomide 5 or 10 mg in Pts with Low- or Int-1-Risk MDS with Del5q: Results From a Randomized Phase III Trial (MDS-004).

Severe Early-Onset Inflammatory Bowel Disease Caused by IL10 Receptor Deficiency Can Be Cured by Allogeneic Hematopoietic Stem Cell Transplantation.

Biclonal expansion and heterogeneous lineage involvement in a case of chronic myeloproliferative disease with concurrent MPL W515L /JAK2 V617F mutation

Ectopic Expression of the Extracellular Domain of Mpl Is Sufficient to Induce a Hematopoietic Population Crisis

Long-Term Cytogenetic Follow-up of MDS Patients with 5q- Treated within the MDS-003 (CC-5013-MDS-003) Study: Evolution to Complex Clones and Progression to AML.

In CML, Marrow Fibrosis Relapses or Emerges in 5 - 6 % of Patients Per Year Independently Indicating Imatinib Failure and Shortened Survival Time of Patients.

Low level of DAP-kinase DNA methylation in myelodysplastic syndrome

Megakaryocytes from chronic myeloproliferative disorders show enhanced nuclear bFGF expression

Cyclin D1 Expression in Mantle Cell Lymphoma Is Accompanied by Downregulation of Cyclin D3 and Is Not Related to the Proliferative Activity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only